Abstracts from the 5th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention

Male circumcision was a key topic of discussion at the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa, 19-22 July 2009. More than 30 abstracts about male circumcision were accepted for oral presentations or poster sessions at the conference, which drew more than 5,800 participants from 123 countries.

The atraumatic circumcision device (AccuCirc) -- a comparison of postoperative outcomes at two weeks. 19-22 July, 2009. Cape Town, South Africa. D. Tomlinson/F.T.K. Fawole/Y. Fawole

Perceived benefits of male circumcision and client preferences for clinic design and marketing of male circumcision in Johannesburg, South Africa. 19-22 July, 2009. Cape Town, South Africa. N. Martinson/F. Selk/J. McIntyre/G. Gray/J. Bridges

Willingness of adolescents to participate in future HIV prevention trials. 19-22 July, 2009. Cape Town, South Africa. J. Dietrich/K. Otwombe/M. Khunwane/M. Van Der Watt/G. De Bruyn/K. Sikkema/G. Gray

Estimating male circumcision resource requirements - a program manager's tool. 19-22 July, 2009. Cape Town, South Africa. J. Campbell/J. Fast/J. Yarrow/M. O'Brien

Human resource constraints and roll-out of male circumcision in Kenya. 19-22 July, 2009. Cape Town, South Africa. G. Odingo/P. Perchal/M. Pavin

Male circumcision and male-to-female HIV-1 transmission risk: a multinational prospective study. 19-22 July, 2009. Cape Town, South Africa. J. Baeten/D. Donnell/M. Inambao/G. John-Stewart/S. Kapiga/R. Manongi/A. Ronald/B. Vwalika/C. Celum

A monitoring and evaluation study to assess the implementation of male circumcision for HIV prevention in Kenya: an interim analysis. 19-22 July, 2009. Cape Town, South Africa. A. Herman-Roloff/R. Bailey/K. Agot/J. Ndinya-Achola

Using health facility assessment data to strategically roll-out male circumcision in Nyanza province, Kenya: a mixed method approach. 19-22 July, 2009. Cape Town, South Africa. A. Herman-Roloff/E. Llewellyn/R. Bailey/K. Agot

Knowledge and attitudes regarding male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant couples in Kampala, Uganda. 19-22 July, 2009. Cape Town, South Africa. K. Mugwanya/J. Baeten/C. Whalen/C. Celum/E. Nakku-Joloba/E. Katabira

Acceptability of male circumcision for the prevention of HIV/AIDS in the Dominican Republic. 19-22 July, 2009. Cape Town, South Africa. M. Brito/H. Balbuena/L. Caso/R. Bailey

Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda. 19-22 July, 2009. Cape Town, South Africa. G. Kigozi/I. Lukabwe/M. Wawer/D. Serwadda/F. Nalugoda/J. Kagayi/N. Kiwanuka/F. Mangen Wabwire/T. Lutalo/D. Nabukenya/G. Kigozi Nalwoga/R. Gray

Lower risk of HIV infection among circumcised MSM: results from the Soweto men's study. 19-22 July, 2009. Cape Town, South Africa. T. Lane/H.F. Raymond/S. Dladla/J. Rasethe/H. Struthers/W. McFarland/J. McIntyre

Informing decision-making on male circumcision for HIV prevention in high HIV prevalence settings: insights from modelling. 19-22 July, 2009. Cape Town, South Africa. C. Hankins/N. Lohse/T. Hallett/N. Nagelkerke/R. White/L. Abu-Raddad/H. Weiss/R. Gray/J. Stover

National sero-prevalence of herpes simplex virus type 2 and co-infection with HIV-1: results of the 2007 Kenya AIDS indicator survey. 19-22 July, 2009. Cape Town, South Africa. N. Mugo/S. Dadabhai/K. Sabin/I. Baya/J. Muttunga/W. Omwomo/R. Bunnell/I. Mohammed/R. Kaiser

Protective sexual behaviours and risk compensation related to male circumcision among men and women in Kisumu, Kenya. 19-22 July, 2009. Cape Town, South Africa. T.H. Riess/M.M. Achieng/S. Otieno/J.O. Ndinya-Achola/R.C. Bailey

Individual self perception of HIV risk is associated with HIV acquisition. 19-22 July, 2009. Cape Town, South Africa. J. Kagaayi/R.H. Gray/A. Ssetuba/F. Nalugoda/G. Kigozi/D. Serwadda/N. Kiwanuka/F. Makumbi/D. Nabukenya/B. Nantume/G. Kigozi/ M.J. Wawer

Emerging trends in funding for research and development of new HIV prevention options. 19-22 July, 2009. Cape Town, South Africa. K. Fisher/C. Feuer/B. Finley/P. Harrison/W. Lee/L. Romero/S. Vuthoori/M. Warren

Herpes simplex type 2 (HSV-2) is associated with HIV acquisition among both placebo and vaccine recipients in the STEP trial of the Merck Adenovirus 5 (MRKAd5) HIV-1 vaccine. 19-22 July, 2009. Cape Town, South Africa. R. Barnabas/Y. Huang/H. Janes/R. Morrow/J. Fuchs/K. Mark/M. Casapia/D. Mehrotra/S. Buchbinder/L. Corey/J. Wasserheit

Is genital human papillomavirus infection associated with HIV incidence? 19-22 July, 2009. Cape Town, South Africa. B. Auvert/P. Lissouba/E. Cutler/K. Zarca/A. Puren/D. Taljaard

An improved device for male circumcision: a modified Yellen style (Gomco) circumcision clamp. 19-22 July, 2009. Cape Town, South Africa. D. Tomlinson/L. Shelton/A. Caldamone

An improved device for male circumcision: a modified Ross style (Plastibell) tourniquet shielding ring. 19-22 July, 2009. Cape Town, South Africa. D. Tomlinson/L. Shelton/A. Caldamone

Male circumcision for prevention of HIV acquistion in heterosexual men: updated Cochrane systematic review provides best evidence. 19-22 July, 2009. Cape Town, South Africa. N. Siegfried/M. Muller/J. Deeks/J. Volmink

Feasibility, acceptability and willingness to participate in a male circumcision trial for the prevention of HIV acquisition in men who have sex with men in the Andes. 19-22 July, 2009. Cape Town, South Africa. P. Goicochea/J. Sanchez/M. Morales/C. Celum

Male circumcision (MC) under local anesthesia: educating clients on the spot. The development of a comprehensive visual package in support of scaling up MC service delivery in priority countries. 19-22 July, 2009. Cape Town, South Africa. I. Schenker/E. Gross/P. Mkhatshwashe

Male circumcision in HIV+ men: effects on HIV viral load. 19-22 July, 2009. Cape Town, South Africa. M.J. Wawer/D. Buwembo/G. Kigozi/D. Serwadda/F. Makumbi/F. Nalugoda/S. Watya/M. Chen/B. Iga/S. Reynolds/R.H. Gray

Hesitations and reservations: an analysis comparing past concerns regarding antiretroviral therapy (ART) roll-out with current apprehension over the scale-up of medical male circumcision (MC) for HIV prevention. 19-22 July, 2009. Cape Town, South Africa. M. Marco/W. El-Sadr

The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model. 19-22 July, 2009. Cape Town, South Africa. V. Lima/A. Anema/R. Wood/D. Moore/R. Harrigan/E. Mills/R. Hogg/J. Montaner

Risk of HIV acquisition among men with and without human papillomavirus infection in Kisumu, Kenya. 19-22 July, 2009. Cape Town, South Africa. J.S. Smith/S. Moses/M. Hudgens/C.B. Parker/K. Agot/I. Maclean/J.O. Ndinya-Achola/P.J.F. Snijders/C.J.L.M. Meijer/R.C. Bailey

HIV sero-prelaence and related risky sexual behaviours among female sex workers (FSWs) in Khartoum State, Sudan. 19-22 July, 2009. Cape Town, South Africa. S.M. Elrashied

Gender differences in risk behavior and the power to negotiate safe sex: potential complications in scaling up adult male circumcision programs in Southern Africa. 19-22 July, 2009. Cape Town, South Africa. K. Andersson/D. Owens/D. Paltiel